了解获得血友病A的治疗护理和延迟:来自加拿大新斯科舍省的一项基于人口的研究
Rachelle Blackman1, Luke Y C Chen1,2, Mary-Margaret Keating1
1Division of Hematology Dalhousie University Halifax Nova Scotia Canada.
EJHaem
|February 25, 2026
概括
获得性血友病A (AHA) 是一种罕见的出血障碍. 这项研究发现新斯科舍省经常出现诊断延迟,突出显示出需要在患有不明原因出血的患者进行及时的凝血检测.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
背景情况:
- 获得性血友病A (AHA) 是一种罕见且严重的出血障碍.
- 它是由针对第八因子 (FVIII) 的自身抗体引起的.
- 描述患者的人口统计和诊断时间表对于改善结果至关重要.
研究的目的:
- 描述加拿大新斯科舍省AHA患者的特征.
- 评估这些患者所经历的诊断延迟.
- 为了确定与延迟诊断相关的因素.
主要方法:
- 进行了一项基于人口的回顾性研究.
- 审查了在中央血友病治疗中心 (2006-2024) 接受AHA治疗的成年人 (≥18岁) 的数据.
- 分析了人口统计,临床表现,治疗,结果和诊断时间表.
主要成果:
- 确定了27例AHA病例,年平均发病率为每百万1.46例.
- 患者的中位年龄为74岁,并发症包括恶性瘤 (26%) 和自身免疫性疾病 (22%).
- 显著的诊断延迟 (≥7天) 在63%的病例中发生,从第一次出血开始的中位时间为32天,从升高的PTT开始的时间为10天;延迟诊断与年轻年龄,疾病严重程度和农村居住有关.
结论:
- 尽管有集中护理,但对AHA的诊断延迟是常见的.
- 早期凝血检测对于出现不明原因出血的患者至关重要.
- 改善诊断时间表可能会提高获得性血友病A患者的治疗结果.
相关概念视频
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Introduction to Hemostasis
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...


